• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Micell Technologies Inc.

Micell raises $62m for MiStent SES

September 19, 2017 By Brad Perriello

Micell Technologies said last week that it raised a debt-and-equity round worth nearly $62 million from a syndicate of 51 unnamed investors. Paris-based Micell makes the MiStent SES sirolimus-eluting absorbable polymer coronary stent, designed to treat coronary artery disease. The company, which reported a nearly $26 million round last November, said in a regulatory filing that the […]

Filed Under: Drug-Device Combinations, Drug-Eluting Stents, Funding Roundup, Wall Street Beat Tagged With: Micell Technologies Inc.

Micell begins MiStent clinical trial in Japan

November 29, 2016 By Sarah Faulkner

Micell Technologies said today that it began its Dessolve J randomized, double-blind study comparing its MiStent SES sirolimus eluting absorbable polymer coronary stent to the Xience V everolimus eluting coronary stent in patients with coronary artery disease. The Durham, N.C.-based company touts its device as a bare-metal stent coated in crystalline drug, sirolimus, and an absorbable polymer, […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Device Combinations, Drug-Eluting Stents Tagged With: Micell Technologies Inc.

Micell Technologies raises $26m

November 18, 2016 By Fink Densford

Micell Technologies raised $25.8 million in a new round of equity and debt financing, according to an SEC filing posted this week. Micell currently produces the MiStent SES sirolimus eluting absorbable polymer coronary stent, designed to treat coronary artery disease. Money in the round came from 51 anonymous sources, according to an SEC filing, with the […]

Filed Under: Business/Financial News Tagged With: Micell Technologies Inc.

TCT 2015 Roundup: St. Jude Medical’s new HeartMate PHP pump

October 14, 2015 By Brad Perriello

St. Jude Medical (NYSE:STJ) said today that its newly acquired HeartMate PHP heart pump met its safety and efficacy endpoints in the Shield I trial used to back its CE Mark approval last summer. The results from Shield I’s 1st 30 patients led to the CE Mark nod in July. Today St. Jude said data from 46 subjects […]

Filed Under: Cardiovascular, Catheters, Clinical Trials Tagged With: Elixir Medical Corp., Micell Technologies Inc., Stentys, stjudemedical, TCT 2015, Tryton Medical Inc.

Micell gains new manufacturing partner

August 20, 2015 By Fink Densford

Micell Technologies said today that it won approval to partner with contract manufacturer Surgical Technologies, Inc. in Britain and will begin full-scale manufacturing of its MiStent SES for distribution to European Union countries. Micell won CE Mark approval in the European Union for the drug-eluting stent in 2013. STI will serve as the primary contract manufacturer of the […]

Filed Under: Business/Financial News, Cardiovascular, Contract Manufacturing, Drug-Eluting Stents Tagged With: Micell Technologies Inc.

Micell launches MiStent SES trial in China

July 22, 2015 By Fink Densford

Micell Technologies said today it launched a Chinese trial of its MiStent SES sirolimus eluting absorbable polymer coronary stent system used to treat coronary artery disease. The prospective, single-blind, multi-center, randomized, controlled Dessolve C trial looks to enroll 428-patients in a study comparing the company’s MiStent SES and the Tivoli bioabsorbable coated stent, which Durham, […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Eluting Stents, Regulatory/Compliance, Stents Tagged With: Micell Technologies Inc.

Micell launches all-comers trial for absorbable-polymer stent

March 23, 2015 By Brad Perriello Leave a Comment

Micell launches all-comers trial for absorbable-polymer stent

Filed Under: News Well Tagged With: Bioabsorbable Stents, Clinical Trials, Distribution, Micell Technologies Inc., Stentys

TCT 2011: Three ways to spur U.S. medical innovation

November 10, 2011 By MassDevice staff Leave a Comment

Dr. Martin Leon

Dr. Martin Leon

The U.S. medical device arena is in danger of ceding the throne to countries with friendlier regulatory environments but the system is not irreparable, Dr. Martin Leon said during a lecture at this week’s Transcatheter Cardiovascular Therapeutics symposium in San Francisco.

Filed Under: Drug-Eluting Stents, News Well, Research & Development Tagged With: Abiomed, Biosensors International Group Ltd., Boston Scientific, Cardiovascular Systems Inc., Clinical Trials, Elixir Medical Corp., InSeal Medical Ltd., Micell Technologies Inc., OrbusNeich, Stent Wars, Transcatheter Cardiovascular Therapeutics symposium (TCT)

Sleep apnea: ImThera touts tongue stimulation treatment | Research roundup

May 12, 2011 By MassDevice staff Leave a Comment

Clinical trials roundup

ImThera Medical Inc. said its tongue stimulation device for sleep apnea can improve patients’ snooze time.

The San Diego-based device maker concluded a European pilot study of its aura6000, an implanted neurostimulation device for treating obstructive sleep apnea (OSA) that delivers electrical pulses to the tongue during sleep.

Filed Under: News Well Tagged With: Abiomed, ArtVentive Medical Group Inc., Calypso Medical Technologies Inc., Cardiofocus, Clinical Trials, Cook Medical, Covidien, Endosense SA, GE Healthcare, ImThera Medical Inc., Micell Technologies Inc.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS